EI
SGYP

EAM Investors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

EAM Investors’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-600,317
Closed -$2.8M – 405
2017
Q1 		$2.8M Buy
+600,317
New +$3.48M 0.44% 109
2016
Q4 		– Sell
-526,602
Closed -$2.9M – 408
2016
Q3 		$2.9M Buy
+526,602
New +$2.47M 0.39% 108
2016
Q1 		– Sell
-647,686
Closed -$3.67M – 384
2015
Q4 		$3.67M Buy
+647,686
New +$3.95M 0.48% 61
2015
Q3 		– Sell
-670,346
Closed -$5.56M – 383
2015
Q2 		$5.56M Buy
+670,346
New +$3.25M 0.65% 13

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return